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It has been reported that relaxation techniques can improve physical
health and cognitive function. A number of studies involving different
types of relaxation practices showed changes in expression of genes.
We investigated the gene expression pattern of a cohort of elderly
subjects of Asian descent after weekly (for the first three months) and
monthly (for the subsequent six months) intervention. Sixty con-
senting elderly subjects (aged 60–90 years) with mild cognitive
impairment were assigned to either the Mindfulness Awareness
Practice (MAP) or Health Education Program (HEP) group in a ran-
domized controlled trial to assess the effectiveness of the programs invier Inc. This is an open access article under the CC BY license
, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore
. Tan).
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Dpreventing further cognitive decline and evaluate the influence on
neurological, cellular and biochemical factors. Blood samples were
collected before the start of intervention and after nine months for
gene expression profiling using Affymetrix Human Genome U133 Plus
2.0 arrays. The dataset is publicly available for further analyses.
& 2018 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Specifications Tableubject area Biology
ore specific subject area Gene expression
ype of data Tables and figures
ow data was acquired Affymetrix GeneChip Human Genome U133 Plus 2.0 Arrays,
Microarray Suite 5, Robust Multi-Array Average and statistical
analysisata format Raw (CEL.) and normalized (CHP.)
xperimental factors Pre-intervention samples collected before the start of each program,
post-intervention samples collected after 9 months of the program
xperimental features Subjects were randomized to one of two groups. One group was
taught Mindfulness Awareness Practice techniques (MAP). The sec-
ond group underwent the Health Education Program (HEP) under
which they received talks on healthy living topics.ata source location National University of Singapore and Research Laboratory, KK
Women's and Children's Hospital, Singaporeata accessibility http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE108215D
Value of the data Practices like yoga, Tai Chi, breathing exercises, and meditation are thought to evoke the relaxation
response that counteracts stress response [1].
 A small study of experienced practitioners showed that mindfulness meditation could influence
expression of genes related to histone modifications and pro-inflammatory genes [2]. There is also
report that after listening to relaxation response-eliciting or health education recordings, healthy adults
showed enhanced expression of genes associated with metabolism and telomere maintenance, while
the expression of genes linked to inflammatory response and stress-related pathways was reduced [3].
 We investigated whether Asian elderly subjects with mild cognitive impairment would show gene
expression changes after undergoing nine months of mindfulness practice program or health education
program.
 The identification of genes and pathways can be used for the development of markers to assess the
effectiveness of the mindfulness practice or other relaxation exercises.1. Data
1.1. Isolation of RNA from blood and globin depletion
The average amount of RNA extracted was 14.88 µg while one sample collected before initiation of
HEP intervention had insufficient RNA for further analysis. After going through GLOBINclear, the yield
Fig. 1. Relative Log Expression plot based on RMA-normalized signal data. Each boxplot represents a sample. The boxplots
presenting the distribution of the log-ratios are centered near 0 and have similar spread.
Table 1
Genes with differentially expressed probesets from unmatched samples analysis using MAS5 normalization.
Group Gene symbol Probesets *p before FDR *p after FDR aFold change
MAP DEC1 220781_at 5.83E − 05 0.75 3.34
Pre: n ¼ 26 CCDC126 228087_at 6.74E − 05 0.75 0.83
Post: n ¼ 17 HTR5A 221362_at 9.18E − 05 0.75 2.08
TMEM259 212575_at 1.01E − 04 0.75 2.69
CKAP2 1554264_at 1.42E − 04 0.84 0.32
FAM27E2/E3 1553590_at 1.84E − 04 0.91 2.22
EFR3B 215328_at 3.44E − 04 0.99 0.39
AP3S1 202442_at 4.44E − 04 0.99 0.89
HEP RAB3GAP2 216057_at 1.53E − 04 0.99 0.28
Pre: n ¼ 24 LOC284788 1557483_at 1.54E − 04 0.99 0.41
Post: n ¼ 19 C11orf30 1569349_at 1.55E − 04 0.99 0.71
FKBP14 235311_at 2.92E − 04 0.99 0.39
FDR ¼ false discovery rate.
* p from ANCOVA after adjusting for batch and gender effects.
a Batch and gender-adjusted fold change.
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912904was between 0.46 and 1.79 µg, with RNA integrity numbers of between 6.6 and 8.9, and 260/280
absorbance ratios of between 1.8 and 2.0 µg.1.2. Microarray gene expression analysis
Relative Log Expression (RLE) of all the samples was at equal level, signal intensity across the
samples were also comparable (Fig. 1). For the pre-MAP and post-MAP analysis using Microarray Suite
5 (MAS5) normalization with log2 transformed, the eight probesets with p-value o 0.0005 (before
FDR correction) from unmatched samples analysis are listed in Table 1, and the gene expression
heatmap in Fig. 2. The corresponding result for the matched samples analysis between pre-MAP and
post-MAP is shown in Table 2. For the group with HEP intervention, the list of probesets which had
p-value o 0.0005 (before FDR correction) from unmatched samples analysis is presented in Table 1,
Fig. 2. Heatmap and dendrogram of the differential gene expression profiles for the eight gene markers generated from
unmatched pre-MAP and post-MAP intervention samples using MAS5.0 normalization before FDR correction. The pre-inter-
vention group is colored in blue and post-intervention group is in red. The relative expression level of each gene among all the
tested samples have been assigned sequentially from dark red color to dark blue color in accordance with low to high
expression level.
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912 905with the heatmap of the gene expression profiles shown in Fig. 3. The corresponding matched
samples analysis result between pre-HEP and post-HEP samples is presented in Table 2.
The list of probesets with p-value o 0.0005 (before FDR correction) between pre- and post-
intervention samples within each intervention group from the analysis using Robust Multi-array
Average (RMA) normalization are presented in Table 3 for unmatched samples analysis whereas
Table 4 shows the corresponding matched samples analysis.
Additional comparison was made between post-MAP and post-HEP samples, the 86 significant
probesets with p-value o 0.05 (after FDR correction) or fold change cut-off (fc 4 1.5 or fc o 0.66)
are listed in Table 5. The heatmap for the corresponding gene expression profiles is shown in Fig. 4.
1.3. Pathway analysis
Analysis using The Database for Annotation, Visualization and Integrated Discovery (DAVID) version
6.8 showed that RAB3GAP2, GRIK2, SCFD1 which are altered following HEP intervention are associated
with disorders related to HDL cholesterol according to the data from the Genetic Association Database
Table 2
Genes with differentially expressed probesets from matched samples analysis using MAS5 normalization.
Group Gene symbol Probesets *p before FDR *p after FDR aFold change
MAP DEC1 220781_at 4.70E − 06 0.14 3.77
Pre: n ¼ 17 TEF 215673_at 8.61E − 05 0.99 0.24
Post: n ¼ 17 CKAP2 1554264_at 2.79E − 04 0.99 0.30
CCDC126 228087_at 3.69E − 04 0.99 0.82
TTLL7 219882_at 3.92E − 04 0.99 2.85
LRRC37A4P 229821_at 4.77E − 04 0.99 1.28
HEP GRIK2 215655_at 1.73E − 04 0.99 0.19
Pre: n ¼ 18 PRKCZ 1569748_at 1.82E − 04 0.99 3.16
Post: n ¼ 18 SLC2A5 230705_at 2.42E − 04 0.99 0.37
LOC284788 1557483_at 2.98E − 04 0.99 0.38
SCFD1 233229_at 3.04E − 04 0.99 0.60
FDR ¼ false discovery rate.
* p from ANCOVA after adjusting for batch effect.
a Batch-adjusted fold change.
Fig. 3. Heatmap and dendrogram of the differential gene expression profiles for the four gene markers generated from
unmatched pre-HEP and post-HEP intervention samples using MAS5.0 normalization before FDR correction. The pre-inter-
vention group is colored in blue and post-intervention group is in red. The relative expression level of each gene among all the
tested samples have been assigned sequentially from dark red color to dark blue color in accordance with low to high
expression level.
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Table 3
Genes with differentially expressed probesets from unmatched samples analysis using RMA normalization.
Group Gene symbol Probesets *p before FDR *p after FDR aFold change
MAP LOC101928211 1559930_at 7.09E − 06 0.21 1.14
Pre: n ¼ 26 B3GNT2 224154_at 2.31E − 04 0.99 1.17
Post: n ¼ 17 LOC100996251 1568892_at 4.44E − 04 0.99 0.88
CSNK1A1 205764_at 4.89E − 04 0.99 0.85
HEP SNAP91 204953_at 1.00E − 04 0.99 1.14
Pre: n ¼ 24 SRSF4 241245_at 1.28E − 04 0.99 0.86
Post: n ¼ 19 FABP6 210445_at 4.00E − 04 0.99 1.20
KCNB2 208123_at 4.32E − 04 0.99 1.15
FDR ¼ false discovery rate.
* p from ANCOVA after adjusting for batch and gender effects.
a Batch and gender-adjusted fold change.
Fig. 4. Heatmap and dendrogram of the differential gene expression profiles for 86 gene markers with at least 1.5 fold up- or
down- regulation, generated from post-intervention HEP and MAP samples using RMA normalization. The HEP group is colored
in blue and MAP group is in red. The relative expression level of each gene among all the tested samples have been assigned
sequentially from dark red color to dark blue color in accordance with low to high expression level.
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Table 4
Genes with differentially expressed probesets from matched samples analysis using RMA normalization.
Group Gene symbol Probesets *p before FDR *p after FDR aFold change
MAP LOC101928211 1559930_at 5.01E − 05 0.99 1.16
Pre: n ¼ 17 PLA2G16 235110_at 1.49E − 04 0.99 1.24
Post: n ¼ 17
HEP RPL23AP53 222225_at 9.42E − 05 0.99 0.81
Pre: n ¼ 18
Post: n ¼ 18
FDR ¼ false discovery rate.
* p from ANCOVA after adjusting for batch effect.
a Batch adjusted fold change.
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912908(GAD), (Table 6). GRIK2 is also found to be involved in other GAD diseases including echocardiography,
triglycerides, tobacco use disorder, autism, schizophrenia, and other psychiatric disorders. None of the
probesets is related to any disease in the Online Mendelian Inheritance in Man (OMIM) database.
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicates that GRIK2 and SLC2A5
which were upregulated for the HEP group are involved in neuroactive ligand-receptor binding
(Table 7).2. Experimental design, materials and methods
2.1. Study design
The study protocol was approved by the National University of Singapore Institutional Review
Board. Sixty elderly who met the criteria below were enrolled:
 Between 60 and 85 years old.
 Living in the community.
 Fulfilled the operational criteria/definition of mild cognitive impairment including at least one age-
education adjusted neuropsychological test Z score o − 1.5, did not meet DSM-IV criteria for
dementia, had memory or cognitive complaint which was corroborated by a reliable informant and
had intact activities of daily living.
 Could function independently.
 Able to travel on their own to participate in the intervention programme.
 Did not have a neurological condition such as epilepsy or Parkinson's disease.
 Did not have a major psychiatric condition such as major depressive disorder.
 Did not suffer from a terminal illness at the time of enrollment.
 Had no marked upper and lower limb motor difficulties.
 Not participating in another interventional study at the same time.
2.2. Intervention
Participants in the MAP group were taught mindfulness awareness practice techniques modelled
on McBee [4]. All participants gathered in a group once a week for 40min for the first 12 weeks,
followed by once a month for 45min for the subsequent 6 months. They were required to practise
these techniques at home daily and keep a record of their practice.
The HEP participants attended weekly talks on healthy living topics such as hypertension, dia-
betes, dementia, depression, medications, exercise, diet, sleep, home safety, falls and social support.
Table 5
Genes with differentially expressed probesets between post-MAP (n ¼ 17) and post-HEP (n ¼ 19) from unmatched samples
analysis using RMA normalization.
Gene symbol Probesets *p before FDR *p after FDR aFold change
LOC101928457 217034_at 1.51E − 15 4.49E − 11 0.57
AHDC1 205002_at 7.54E − 14 1.12E − 09 0.51
ENTHD2 239681_at 1.40E − 13 1.39E − 09 0.62
MIR6716///PHLDB1 212134_at 1.46E − 12 1.08E − 08 0.63
CLEC14A 226244_at 8.10E − 12 4.80E − 08 0.60
LINC00482 243263_at 6.88E − 11 2.27E − 07 0.66
NDUFS1 239268_at 1.12E − 10 3.02E − 07 0.65
C9orf172 236744_at 3.01E − 10 6.86E − 07 0.59
GALNT5 232110_at 3.30E − 10 7.00E − 07 0.58
LOC101928104 217471_at 3.76E − 10 7.44E − 07 0.61
TGFB2 228121_at 4.81E − 10 8.40E − 07 0.55
WWC1 229180_at 1.16E − 09 1.73E − 06 0.60
IKZF4 208472_at 1.74E − 09 2.15E − 06 0.64
KLK14 220573_at 2.64E − 09 2.80E − 06 0.56
LOC283278///PLEKHA7 242417_at 3.69E − 09 3.25E − 06 0.63
UBA6 1555441_at 4.88E − 09 3.92E − 06 0.64
CDC42BPA 203794_at 6.07E − 09 4.40E − 06 0.62
MYCNOS 207028_at 6.46E − 09 4.46E − 06 0.61
C21orf58 238541_at 6.37E − 09 4.46E − 06 0.63
GAS6-AS1 238127_at 6.81E − 09 4.52E − 06 0.51
BPIFC 1555773_at 7.86E − 09 4.95E − 06 0.65
TMC4 226403_at 8.09E − 09 4.95E − 06 0.61
LINC01106///LINC01123 242222_at 1.37E − 08 6.99E − 06 0.61
WDR64 1553373_at 1.98E − 08 9.77E − 06 0.65
ZCCHC5 1552935_at 2.37E − 08 1.00E − 05 0.62
SLC28A1 207560_at 2.37E − 08 1.00E − 05 0.64
SYNE4 235515_at 2.31E − 08 1.00E − 05 0.63
AC100830.4 238024_at 6.99E − 08 2.38E − 05 0.65
MTMR9LP 228593_at 8.74E − 08 2.76E − 05 0.66
KIAA2026 236306_at 9.68E − 08 2.90E − 05 0.64
LINC01208 237274_at 9.62E − 08 2.90E − 05 0.65
LOC101927703 241787_at 9.94E − 08 2.92E − 05 0.63
LOC100130502 1570568_at 2.27E − 07 5.26E − 05 0.61
CHRNA3 210221_at 2.45E − 07 5.47E − 05 0.64
UCA1 227919_at 3.51E − 07 6.92E − 05 0.64
PNPLA7 228383_at 3.67E − 07 7.02E − 05 0.65
RC3H2 238421_at 4.32E − 07 8.12E − 05 0.66
ANO4 229749_at 5.52E − 07 9.63E − 05 0.63
RP11-805I24.3 244284_at 6.59E − 07 1.12E − 04 0.62
PADI1 223739_at 7.83E − 07 1.28E − 04 0.61
MOGAT2 232428_at 8.68E − 07 1.37E − 04 0.64
KIF18B 222039_at 1.10E − 06 1.62E − 04 0.63
RP11-774O3.1///RP11-774O3.2 243408_at 1.12E − 06 1.63E − 04 0.65
PTGFRN 224950_at 1.29E − 06 1.83E − 04 0.61
FFAR1 231761_at 1.30E − 06 1.84E − 04 0.58
TMEM57 241364_at 1.86E − 06 2.39E − 04 0.54
HIST1H2AM 214481_at 2.39E − 06 2.76E − 04 0.63
EPS15L1 243482_at 2.48E − 06 2.82E − 04 0.61
SKA3 227165_at 3.09E − 06 3.22E − 04 0.65
WFIKKN2 241358_at 4.44E − 06 4.13E − 04 0.65
PRR15L 219127_at 5.80E − 06 4.99E − 04 0.61
ZFP57 231236_at 1.17E − 05 8.33E − 04 0.61
CCDC154 244409_at 1.35E − 05 9.29E − 04 0.66
PCDH17 205656_at 2.55E − 05 1.45E − 03 0.65
CAV2 203323_at 2.74E − 05 1.52E − 03 0.65
GTF2A2 243985_at 4.30E − 05 2.10E − 03 0.65
KRTAP5-2 1566218_at 1.04E − 04 3.85E − 03 0.66
DYNC1I2 236698_at 1.05E − 04 3.87E − 03 0.63
IRF5 239412_at 1.41E − 04 4.70E − 03 0.46
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Table 5 (continued )
Gene symbol Probesets *p before FDR *p after FDR aFold change
TPBG 203476_at 1.76E − 04 5.41E − 03 0.58
CACNB4 207693_at 1.90E − 04 5.75E − 03 0.65
TRIM67 233357_at 2.05E − 04 6.03E − 03 0.60
IQGAP3 241939_at 2.72E − 04 7.43E − 03 0.62
DQ592442 1558444_at 2.78E − 04 7.53E − 03 0.58
MAOA 212741_at 1.17E − 03 1.97E − 02 0.60
OLFM1 213131_at 4.26E − 03 4.62E − 02 0.56
MIR146A 238225_at 4.60E − 11 1.71E − 07 1.67
PYROXD1 231173_at 1.49E − 09 2.04E − 06 1.91
SEZ6 229651_at 2.07E − 09 2.33E − 06 1.53
ILDR1 1553545_at 2.90E − 09 2.87E − 06 1.59
ATG12 213930_at 3.00E − 09 2.87E − 06 1.76
TMCO3 220241_at 3.84E − 09 3.25E − 06 1.66
ANKRD11 226012_at 5.33E − 09 4.09E − 06 1.60
RP11-876N24.5 1569127_at 1.00E − 08 5.82E − 06 1.66
CCDC120 239403_at 1.29E − 08 6.83E − 06 1.55
STYX 242408_at 2.63E − 08 1.09E − 05 1.57
SH3BP2 217253_at 7.30E − 08 2.46E − 05 1.50
TIAL1 202405_at 2.68E − 07 5.70E − 05 1.69
AC018766.6 235665_at 1.07E − 06 1.61E − 04 1.57
TNPO2 215844_at 3.07E − 05 1.66E − 03 1.51
GGACT 232422_at 4.35E − 05 2.11E − 03 1.67
CAAP1 231995_at 3.16E − 04 8.15E − 03 1.55
RP11-722E23.2 237419_at 9.47E − 04 1.70E − 02 1.55
CLEC12A 243106_at 1.14E − 03 1.94E − 02 2.06
COPG2 223457_at 3.34E − 03 3.96E − 02 1.51
ZNF44 228718_at 3.58E − 03 4.12E − 02 1.50
FDR ¼ false discovery rate.
* p from ANCOVA after adjusting for batch and gender effects.
a Batch and gender-adjusted fold change.
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912910The sessions were led by an instructor who had experience conducting similar teaching sessions for
the elderly. Participants were provided with hand-outs at each session and were also required to keep
a record of activities to complete in-between sessions. The sessions were weekly for 40min for the
first 12 weeks, and then once a month for 6 months.
2.3. Samples and RNA preparation
Blood samples (1–3ml) were collected in Tempus Blood RNA Tube from 51 subjects before the
start of intervention (pre-intervention samples) and 36 subjects after nine months (post-intervention
samples). The blood tubes were stored in the freezer at − 80 °C and processed in batches. Total RNA
was extracted using Tempus Spin RNA Isolation Kit (Applied Biosystems, CA, USA). The purity and
concentration of the total RNA were determined by UV–vis Spectrophotometer (Quawell, CA, USA)
and Quantus Fluorometer (Promega, WI, USA). Globin mRNA depletion was performed with a mini-
mum of 800 ng of total RNA using the GLOBINclear Kit (Ambion, TX, USA). The purity and con-
centration of the GLOBINclear RNA were determined by UV–vis Spectrophotometer and Quantus
Fluorometer, respectively. The integrity of the GLOBINclear RNA was evaluated by RNA ScreenTape
assay (Agilent Technologies, Waldbronn, Germany).
2.4. Microarray and quality control
Eighty-seven samples (51 pre-intervention, 36 post-intervention) were processed in batches of 4–
12 samples. cRNA was synthesised from 100 ng of GLOBINclear RNA using GeneChip 3’ IVT PLUS
Reagent Kit according to the manufacturer's protocol. Fragmented and labeled cRNA (11 µg) was
Table 6
Genes involved in GAD disease.
GAD disease Probesets Gene *p-value
Cholesterol, HDL 216057_at RAB3GAP2 0.042
215655_at GRIK2
233229_at SCFD1
Tobacco Use Disorder 1569349_at C11orf30 0.188
215655_at GRIK2
202442_at AP3S1
233229_at SCFD1
230705_at SLC2A5
Several psychiatric disorders 215655_at GRIK2 0.208
221362_at HTR5A
Autism 215655_at GRIK2 0.244
221362_at HTR5A
Echocardiography 215655_at GRIK2 0.261
233229_at SCFD1
Triglycerides 215655_at GRIK2 0.290
233229_at SCFD1
Schizophrenia 215655_at GRIK2 0.464
221362_at HTR5A
Thresholds set at minimum count of 2 and maximum EASE score (p-value) of 0.5.
* p-value of a modified Fisher's exact test (EASE score) from DAVID.
Table 7
Genes involved in KEGG pathway.
KEGG pathway Probesets Gene *p-value
Neuroactive ligand-receptor interaction 215655_at, GRIK2 0.12
221362_at HTR5A
Thresholds set at minimum count of 2 and maximum EASE score (p-value) of 0.5.
* p-value of a modified Fisher's exact test (EASE score) from DAVID.
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912 911hybridised to Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays according to the manu-
facturer's protocol. Arrays were scanned using the Affymetrix GeneChip 3000 7G with autoloader and
the captured images were analyzed using Affymetrix GeneChip Command Console version 4.3.2.
Metric analysis was carried out according to the instructions provided by manufacturer using the
Affymetrix Expression Console 1.4.1.46. Relative Log Expression (RLE) generated from RMA normal-
ization using Affymetrix Expression Console was used to ensure the compatibility across the all
samples and identify the outliers.
All available data were used to compare the difference in gene expression between pre- and post-
intervention for unmatched samples analysis of each intervention group. For matched samples
analysis, only data from subjects with both pre- and post-intervention RNA samples were included. A
total of 29,663 probesets with unique gene annotation were selected out of 54,676 raw probesets for
analysis. Analysis of Covariance (ANCOVA) was performed for both unmatched samples analysis and
matched samples analysis. Batch and gender effects were adjusted for the unmatched sample analysis
H.-W. Lim et al. / Data in Brief 18 (2018) 902–912912while only batch effect was adjusted in the matched sample analysis. Array data was normalized
using (i) Microarray Suite 5 (MAS5) and subsequently log2 transformed, and (ii) Robust Multi-array
Average (RMA) methods [5]. R software was used for normalization and differential gene expression
analysis, and control of the false discovery rate (FDR) for multiple testing [6]. Gene expression is
considered to show up-regulation in the post-intervention group if the adjusted fold change is more
than 1.5 and downregulation if the adjusted fold change is less than 0.66. P-values o 0.05 (after FDR)
were considered as statistically significant for differential gene expression (Tables 1–5).
Hierarchical clustering was applied to both samples and signature gene set for (i) before FDR for
pre-/post-HEP, (ii) pre-/post-MAP, (iii) after FDR and fold change cut-off (FC 4 1.5 or FC o 0.66) for
post-HEP/post-MAP, shown in the format of dendrogram in combination with a heatmap of gene
expression levels.
2.5. Pathway analysis
The differentially expressed genes from MAS5 normalization were used for enrichment analysis of
pathways and diseases using version 6.8 of DAVID [7]. The list of probesets from Tables 1 and 2 was
entered into the web application (david.ncifcrf.gov), with “AFFYMETRIX_3PRIME_IVT_ID” selected as
the gene identifier and Homo sapiens selected as the species. Diseases were identified by the GAD and
OMIM databases, and biochemical pathway by KEGG. Gene enrichment in annotation terms was
measured by modified Fisher's exact test (EASE score). Functional annotation chart was visualized
using minimum of 2 count and maximum EASE score (p-value) of 0.5. EASE score (p-value) of o 0.05
was considered as statistically significant (Tables 6 and 7).Acknowledgements
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